Randomised, double-blind, placebo-controlled, multi-centre trial on the efficacy and safety of budesonide for induction of remission in incomplete microscopic colitis
Phase of Trial: Phase III
Latest Information Update: 24 Jul 2017
At a glance
- Drugs Budesonide (Primary)
- Indications Microscopic colitis
- Focus Registrational; Therapeutic Use
- Sponsors Dr Falk Pharma
- 02 Feb 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018.
- 02 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 09 Mar 2014 New trial record